We are live on ! Find out more
TXMD icon

TherapeuticsMD
TXMD

53 hedge funds and large institutions have $200M invested in TherapeuticsMD in 2013 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 22 increasing their positions, 17 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 6

29% more repeat investments, than reductions

Existing positions increased: 22 | Existing positions reduced: 17

25% more capital invested

Capital invested by funds: $160M → $200M (+$40.6M)

13% more funds holding

Funds holding: 47 → 53 (+6)

0.24% more ownership

Funds ownership: 0.8% → 1.04% (+0.24%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

Holders
53
Holders Change
+6
Holders Change %
+12.77%
% of All Funds
1.72%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
12
Increased
22
Reduced
17
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
RCM
RA Capital Management
Massachusetts
+$12.7M
2
GGHC
Gilder Gagnon Howe & Co
New York
+$6.67M
3
Wellington Management Group
Wellington Management Group
Massachusetts
+$5.34M
4
BC
Broadfin Capital
New York
+$5.15M
5
DM
Deerfield Management
New York
+$3.02M

Top Sellers

Rank Fund Capital Flow
1
SM
Sabby Management
Florida
-$944K
2
FTUS
Flow Traders U.S.
New York
-$378K
3
Goldman Sachs
Goldman Sachs
New York
-$293K
4
Bank of America
Bank of America
North Carolina
-$287K
5
Citigroup
Citigroup
New York
-$160K
Name Holding Trade Value Shares
Change 		Change in
Stake
Wellington Management Group
1
Wellington Management Group
Massachusetts
$59.5M +$5.34M +44,149 +12%
RCM
2
RA Capital Management
Massachusetts
$48.4M +$12.7M +105,321 +47%
Fidelity Investments
3
Fidelity Investments
Massachusetts
$29.5M -$126K -1,046 -0.5%
Franklin Resources
4
Franklin Resources
California
$10.2M +$1.92M +15,914 +30%
GGHC
5
Gilder Gagnon Howe & Co
New York
$9.59M +$6.67M +55,180 +536%
BFA
6
BlackRock Fund Advisors
California
$6.45M +$617K +5,100 +13%
BC
7
Broadfin Capital
New York
$6.24M +$5.15M +42,563 New
Millennium Management
8
Millennium Management
New York
$5.51M +$511K +4,230 +13%
DM
9
Deerfield Management
New York
$3.66M +$3.02M +25,000 New
Vanguard Group
10
Vanguard Group
Pennsylvania
$3.3M +$192K +1,587 +8%
BIT
11
BlackRock Institutional Trust
California
$2.66M +$190K +1,572 +9%
Northern Trust
12
Northern Trust
Illinois
$2.64M +$1.54M +12,699 +239%
State Street
13
State Street
Massachusetts
$2.33M +$102K +846 +6%
GH
14
GAM Holding
Switzerland
$1.25M +$326K +2,694 +46%
GPP
15
Great Point Partners
Connecticut
$1.22M +$1.01M +8,333 New
OA
16
Outfitter Advisors
Virginia
$1.01M -$28.7K -237 -3%
TCIM
17
TIAA CREF Investment Management
New York
$935K +$5.68K +47 +0.7%
Bank of New York Mellon
18
Bank of New York Mellon
New York
$741K -$3.27K -27 -0.5%
BIM
19
BlackRock Investment Management
Delaware
$642K +$45.5K +376 +9%
Geode Capital Management
20
Geode Capital Management
Massachusetts
$507K +$36K +298 +9%
Charles Schwab
21
Charles Schwab
California
$411K +$7.98K +66 +3%
California State Teachers Retirement System (CalSTRS)
22
California State Teachers Retirement System (CalSTRS)
California
$409K +$8.95K +74 +3%
TA
23
Teachers Advisors
New York
$342K +$31.7K +262 +13%
UOC
24
UBS O'Connor
Illinois
$293K +$242K +2,000 New
Deutsche Bank
25
Deutsche Bank
Germany
$271K +$37.8K +313 +20%
1
2 3

TXMD Hedge Fund Activity: Q3 2013 in Review

53 of the 3,085 institutional investors tracked by Wall St. Rank reported a position in TherapeuticsMD (TXMD) for Q3 2013, worth a combined $200M — up 25% from $160M a quarter earlier.

Buyers outnumbered sellers: 12 funds opened new TXMD positions and 6 closed out — a net gain of 6 holders — while 22 added to existing stakes and 17 trimmed.

The largest buyer was RA Capital Management, adding an estimated $12.7M. The largest seller was Sabby Management, exiting entirely with an estimated $944K sold.

  • 53 institutional investors held TherapeuticsMD (TXMD) as of Q3 2013, up from 47 in Q2 2013.
  • Funds reported $200M of TherapeuticsMD stock for Q3 2013, up 25% quarter-over-quarter.
  • 12 funds opened new TherapeuticsMD positions in Q3 2013 and 6 closed out, a net change of +6 holders.
  • The largest TherapeuticsMD buyer in Q3 2013 was RA Capital Management, an estimated $12.7M added.
  • The largest TherapeuticsMD seller in Q3 2013 was Sabby Management, an estimated $944K sold.

Based on aggregated 13F filings for Q3 2013.